Aurinia Pharmaceuticals reported revenue of $83.22M and net income of $37.41M for the quarter ended Jun 2026, up 18.9% year over year. This income statement covers 30 quarters of results from Dec 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2016 | Dec2017 | Dec2018 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||||||||
| Revenue | 14.67M | 23.40M | 21.62M | 28.19M | 55.78M | 28.43M | 34.41M | 41.49M | 54.52M | 45.09M | 50.30M | 57.19M | 67.77M | 59.87M | 62.47M | 70.01M | 73.47M | 77.11M | 77.70M | 83.22M | ||||||||||
| Cost of RevenueCost of Rev | 0.25M | 0.48M | 0.26M | 1.60M | 2.45M | 1.36M | 0.42M | 1.56M | 6.77M | 5.39M | 7.75M | 8.91M | 6.04M | 5.55M | 8.57M | 7.12M | 8.18M | 8.80M | 6.50M | 6.55M | ||||||||||
| Gross Profit | 14.41M | 22.92M | 21.37M | 26.59M | 53.33M | 27.07M | 33.99M | 39.93M | 47.75M | 39.70M | 42.55M | 48.28M | 61.74M | 54.31M | 53.89M | 62.89M | 65.29M | 68.31M | 71.20M | 76.67M | ||||||||||
| Operating items | ||||||||||||||||||||||||||||||
| Amortization - Intangibles | 0.52M | 0.50M | ||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 20.07M | 11.15M | 12.62M | 11.53M | 10.97M | 9.87M | 13.16M | 12.65M | 13.61M | 10.23M | 5.55M | 4.08M | 3.05M | 8.11M | 5.74M | 7.43M | 8.44M | 10.89M | 7.47M | 13.05M | ||||||||||
| Selling, General & AdministrativeSG&A | 44.65M | 44.76M | 45.20M | 51.53M | 52.17M | 47.47M | 50.12M | 47.08M | 47.76M | 50.07M | 47.70M | 44.93M | 42.37M | 37.03M | 20.34M | 26.02M | 26.18M | 29.25M | 22.03M | 23.51M | ||||||||||
| Restructuring CostsRestructuring | 6.68M | 1.07M | 15.35M | 1.53M | 0.11M | |||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | -0.06M | 0.28M | -1.43M | 0.48M | 0.31M | 2.17M | -0.29M | 3.63M | -2.65M | -9.07M | 4.12M | 0.29M | -4.57M | 4.51M | -4.43M | -9.25M | -0.93M | 5.07M | -0.28M | 6.23M | ||||||||||
| Operating ExpensesOpex | 65.02M | 56.11M | 59.51M | 64.18M | 65.28M | 56.53M | 63.99M | 57.66M | 70.78M | 74.77M | 63.56M | 58.70M | 56.02M | 61.54M | 40.62M | 49.92M | 43.72M | 43.88M | 36.28M | 36.88M | ||||||||||
| Operating IncomeOp. Inc | -50.35M | -32.70M | -37.88M | -35.99M | -9.50M | -28.10M | -29.58M | -16.17M | -16.26M | -29.67M | -13.25M | -1.51M | 11.75M | -1.67M | 21.85M | 20.08M | 29.75M | 33.24M | 41.42M | 46.34M | ||||||||||
| EBIT | -50.35M | -32.70M | -37.88M | -35.99M | -9.50M | -28.10M | -29.58M | -16.17M | -16.26M | -29.67M | -13.25M | -1.51M | 11.75M | -1.67M | 21.85M | 20.08M | 29.75M | 33.24M | 41.42M | 46.34M | ||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.07M | 1.40M | 1.31M | 1.28M | 1.20M | 1.21M | 1.15M | 1.07M | 1.12M | 1.10M | 1.05M | 1.01M | 0.95M | |||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.11M | 0.11M | 0.26M | 0.48M | 1.46M | 2.91M | 3.81M | 4.10M | 4.51M | 4.57M | 4.53M | 4.19M | 4.27M | 3.99M | 3.57M | 3.19M | 3.32M | 3.50M | 3.52M | 3.39M | ||||||||||
| Net income details | ||||||||||||||||||||||||||||||
| EBT | -50.25M | -32.60M | -37.62M | -35.51M | -8.04M | -25.19M | -25.77M | -12.13M | -13.15M | -26.42M | -10.01M | 1.48M | 14.81M | 1.17M | 24.35M | 22.16M | 31.96M | 35.69M | 43.92M | 48.79M | ||||||||||
| Tax ProvisionsTaxes | 0.01M | 0.73M | 0.01M | 0.01M | 0.95M | 0.85M | 0.44M | -0.64M | 0.30M | 0.45M | 0.74M | 0.80M | 0.50M | -0.30M | 1.00M | 0.64M | 0.41M | -175.15M | 9.60M | 11.40M | ||||||||||
| Profit After TaxPAT | -50.26M | -33.32M | -37.63M | -35.52M | -8.99M | -26.05M | -26.21M | -11.49M | -13.45M | -26.88M | -10.75M | 0.72M | 14.35M | 1.43M | 23.34M | 21.51M | 31.55M | 210.79M | 34.35M | 37.41M | ||||||||||
| Income from Continuing OperationsIncome (Continuing) | -50.26M | -33.32M | -37.63M | -35.52M | -8.99M | -26.05M | -26.21M | -11.49M | -13.45M | -26.87M | -10.75M | 0.68M | 14.31M | 1.48M | 23.34M | 21.51M | 31.55M | 210.84M | 34.33M | 37.39M | ||||||||||
| Consolidated Net IncomeConsol Net Inc. | -50.26M | -33.32M | -37.63M | -35.52M | -8.99M | -26.05M | -26.21M | -11.49M | -13.45M | -26.87M | -10.75M | 0.68M | 14.31M | 1.48M | 23.34M | 21.51M | 31.55M | 210.84M | 34.33M | 37.39M | ||||||||||
| Income towards Parent CompanyParent Net Inc | -50.26M | -33.32M | -37.63M | -35.52M | -8.99M | -26.05M | -26.21M | -11.49M | -13.45M | -26.87M | -10.75M | 0.68M | 14.31M | 1.48M | 23.34M | 21.51M | 31.55M | 210.84M | 34.33M | 37.39M | ||||||||||
| Net Income towards Common StockholdersNet Income | -50.26M | -33.32M | -37.63M | -35.52M | -8.99M | -26.05M | -26.21M | -11.49M | -13.45M | -26.87M | -10.75M | 0.68M | 14.31M | 1.48M | 23.34M | 21.51M | 31.55M | 210.84M | 34.33M | 37.39M | ||||||||||
| Additional items | ||||||||||||||||||||||||||||||
| EPS (Basic) | -0.39 | -0.26 | -0.27 | -0.25 | -0.06 | -0.18 | -0.18 | -0.08 | -0.09 | -0.19 | -0.07 | 0.00 | 0.10 | 0.01 | 0.17 | 0.16 | 0.24 | 1.57 | 0.26 | 0.29 | ||||||||||
| EPS (Diluted) | -0.39 | -0.26 | -0.27 | -0.25 | -0.06 | -0.18 | -0.18 | -0.08 | -0.09 | -0.19 | -0.07 | 0.00 | 0.10 | 0.01 | 0.16 | 0.16 | 0.23 | 1.52 | 0.25 | 0.28 | ||||||||||
| Shares Outstanding | 128.44M | 129.37M | 141.68M | 141.73M | 141.86M | 141.91M | 142.64M | 142.78M | 142.85M | 143.24M | 144.01M | 143.33M | 143.05M | 143.06M | 138.92M | 134.87M | 131.81M | 134.37M | 132.38M | 130.08M | ||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 128.44M | 129.37M | 141.68M | 141.73M | 141.86M | 141.91M | 142.64M | 142.78M | 142.85M | 143.24M | 144.01M | 144.11M | 145.65M | 146.19M | 143.20M | 137.53M | 136.01M | 138.70M | 137.64M | 133.53M | ||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 129.60M | 141.60M | 141.74M | 141.89M | 142.11M | 142.27M | 143.03M | 143.37M | 143.60M | 143.83M | 143.69M | 142.98M | 143.11M | 140.88M | 137.75M | 132.67M | 131.84M | 132.32M | 130.77M | 132.91M | ||||||||||
| EBITDA | -50.35M | -32.70M | -37.88M | -35.99M | -9.50M | -28.10M | -29.58M | -16.17M | -16.26M | -29.67M | -13.25M | -1.51M | 11.75M | -1.67M | 21.85M | 20.08M | 29.75M | 33.24M | 41.42M | 46.34M | ||||||||||
| Interest ExpensesInt Expense | 0.07M | 1.40M | 1.31M | 1.28M | 1.20M | 1.21M | 1.15M | 1.07M | 1.12M | 1.10M | 1.05M | 1.01M | 0.95M | |||||||||||||||||
| Tax Rate | -0.02% | -2.23% | -0.03% | -0.03% | -11.87% | -3.39% | -1.69% | 5.29% | -2.28% | -1.71% | -7.38% | 54.13% | 3.38% | -25.92% | 4.13% | 2.90% | 1.29% | -490.74% | 21.86% | 23.37% |